Search results for "Time factor"

showing 10 items of 3219 documents

Publisher Correction: Anticipatory postural adjustments during joint action coordination

2019

There is a current claim that humans are able to effortlessly detect others' hidden mental state by simply observing their movements and transforming the visual input into motor knowledge to predict behaviour. Using a classical paradigm quantifying motor predictions, we tested the role of vision feedback during a reach and load-lifting task performed either alone or with the help of a partner. Wrist flexor and extensor muscle activities were recorded on the supporting hand. Early muscle changes preventing limb instabilities when participants performed the task by themselves revealed the contribution of the visual input in postural anticipation. When the partner performed the unloading, a co…

AdultMalemedicine.medical_specialtyMultidisciplinaryTime FactorsElectromyographyPublished ErratumMovementlcsh:RPostureMEDLINElcsh:MedicineHandPublisher CorrectionJoint actionPhysical medicine and rehabilitationmedicineHumanslcsh:QFemaleJointsPsychologylcsh:ScienceMuscle SkeletalScientific Reports
researchProduct

Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline

2016

Purpose The aim of this 10-year follow-up study was to determine changes in health-related quality of life (HRQoL) over time among ambulatory persons with MS (PwMS) at the baseline using generic and disease-specific instruments. Methods Of 109 independently walking PwMS included in a population-based study in 2002, 77 (70.6 %) were re-assessed in 2012. HRQoL was captured using the 36-Item Short Form Survey Instrument (RAND-36), 15D instrument (15D), and the Multiple Sclerosis Quality of Life-54 (MSQOL-54). Repeated-measures ANOVA and effect size (ES) calculations (Cohen’s d) were used in the statistical analysis. Results The RAND-36 physical health composite score (p = 0.003, ES = 0.26) and…

AdultMalemedicine.medical_specialtyMultiple SclerosisTime FactorsPopulationelämänlaatu03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationQuality of lifeMS-tautiSickness Impact ProfileSurveys and QuestionnairesmedicineHumans030212 general & internal medicinePatient Reported Outcome MeasureseducationSocial functioningAgedHealth related quality of lifeAged 80 and overeducation.field_of_studySexual functioningbusiness.industryMultiple sclerosisPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseasepatient-reported outcomesAmbulatoryPhysical therapyFemaleAnalysis of variancebusinessterveys030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.

1995

Islet cell antigen (ICA) 69 is a newly-recognized islet cell antigen to which autoantibodies have been observed in prediabetic relatives of patients with insulin-dependent-diabetes mellitus (IDDM). Here we extend the earlier analysis of ICA69 antibodies to patients with recent-onset IDDM and to patients with other immune-mediated diseases. ICA69 antibodies were determined by Western blot using an affinity purified recombinant fusion protein of ICA69 and maltose binding protein. ICA69 antibody quantities were determined as titres using a titration curve of a standard serum as reference. Mean logarithmic ICA69 antibody titres were 3.4 (+/- 1.4) in 99 patients with acute IDDM compared to 2.8 (…

AdultMalemedicine.medical_specialtyMultiple SclerosisTime Factorsendocrine system diseasesAdolescentEndocrinology Diabetes and MetabolismRecombinant Fusion ProteinsBlotting WesternArthritisAutoantigensArthritis RheumatoidAntigenCrohn DiseaseInternal medicineImmunopathologyInternal MedicinemedicineHumansFamilyChildAutoantibodiesAutoimmune diseasegeographygeography.geographical_feature_categorybiologybusiness.industryAutoantibodyThyroiditis AutoimmuneInfantMiddle AgedIsletmedicine.diseaseGraves DiseaseEndocrinologyDiabetes Mellitus Type 1Rheumatoid arthritisChild PreschoolImmunologybiology.proteinColitis UlcerativeFemaleAntibodybusinessFollow-Up StudiesDiabetologia
researchProduct

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria

2018

MRI has been formally included in the diagnostic work-up of patients with a suspicion of multiple sclerosis (MS) in 2001, to demonstrate disease dissemination in space (DIS) and time (DIT) and to exclude alternative diagnoses.1 Over time, these criteria have been modified to simplify their use and to clarify specific aspects (eg, spinal cord findings).2 One aspect marginally analysed in the diagnostic work-up of patients with clinically isolated syndrome (CIS) is the role of intracortical lesions (ICLs), which are a prominent feature of MS and contribute to disability and cognitive impairment.2 A single-centre study3 showed that inclusion of ICL for the evaluation of DIS in CIS increased th…

AdultMalemedicine.medical_specialtyMultiple SclerosisTime Factorsmultiple sclerosis030218 nuclear medicine & medical imagingCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineMedicineHumansMRI; multiple sclerosisProspective StudiesMedical diagnosisProspective cohort studymriCerebral CortexClinically isolated syndromemedicine.diagnostic_testbusiness.industryMultiple sclerosisBrainMagnetic resonance imagingMiddle Agedmedicine.diseaseInstitutional review boardMagnetic Resonance ImagingSurgeryPsychiatry and Mental healthSpinal CordCohortSurgeryFemaleNeurology (clinical)Radiologybusiness030217 neurology & neurosurgeryMRICohort studyDemyelinating Diseases
researchProduct

Cigarette Smoking Status at Diagnosis and Recurrence in Intermediate-risk Nonemuscle-invasive Bladder Carcinoma

2013

Objective To study the effect of smoking status at diagnosis on recurrence in intermediate-risk non–muscle-invasive bladder carcinoma treated by transurethral resection (TUR) of the bladder and early intravesical chemotherapy. Methods Tumor characteristics and smoking status were recorded in 395 patients entered in a randomized multicenter trial comparing 2 different schedules of early intravesical chemotherapy. All patients received intravesical epirubicin (80 mg/50 mL) within 6 hours after TUR, followed by 5 more weekly instillations with (arm B) or without (arm A) monthly instillations for 1 year. Smoking habit was investigated at diagnosis through a structured questionnaire. Multivariat…

AdultMalemedicine.medical_specialtyMultivariate analysisTime Factorsintravesical chemotherapy non-muscle invasive bladder cancerUrologymedicine.medical_treatmentcigarette smokingKaplan-Meier EstimateCystectomyGastroenterologyDisease-Free SurvivalSettore MED/24 - UrologiaCystectomyCigarette smokingRisk FactorsMulticenter trialInternal medicinemedicineCarcinomaHumansAgedEpirubicinProportional Hazards ModelsAged 80 and overAntibiotics AntineoplasticProportional hazards modelbusiness.industryCarcinomaSmokingMiddle AgedFormer Smokermedicine.diseaseintermediate-risk tumorrecurrence.Combined Modality TherapySurgeryUrinary Bladder NeoplasmsMultivariate AnalysisFemaleNeoplasm Recurrence LocalbusinessEpirubicinmedicine.drug
researchProduct

An 18-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Moderate Nasolabial Folds

2016

Hyaluronic acid (HA) filler injection is a popular nonsurgical aesthetic procedure.To compare the effectiveness and safety of 2 hyaluronic acid fillers (HAEC and HARES) for treatment of moderate nasolabial folds (NLFs).This was an evaluator- and subject-blinded split-face study. HAEC or HARES was randomly assigned to the left or right NLF at baseline. Retreatment was performed after 9 months; follow-up extended to 18 months after baseline (9 months after retreatment). Effectiveness assessments included the Wrinkle Severity Rating Scale (WSRS) and subject preference. Safety assessments included adverse events (AEs) and local tolerability symptoms recorded by subjects during 3 weeks after tre…

AdultMalemedicine.medical_specialtyNasolabial FoldTime FactorsTreatment outcomeDermatology030230 surgerylaw.invention030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodRandomized controlled triallawDermal FillersHyaluronic acidmedicineHumansHyaluronic AcidAgedbusiness.industryFollow up studiesPatient PreferenceGeneral MedicineMiddle AgedNasolabial foldPatient preferenceSkin AgingSurgeryTreatment Outcomemedicine.anatomical_structureMulticenter studychemistryRetreatmentFemaleSurgerybusinessFollow-Up StudiesMonth follow upDermatologic Surgery
researchProduct

Detection of possible factors favouring the evolution of migraine without aura into chronic migraine

2012

In a minority of cases, the natural history of migraine without aura (MO) is characterised over time by its evolution into a form of chronic migraine (CM). In order to detect the possible factors predicting this negative evolution of MO, we searched in our Headache Centre files for all clinical records that met the following criteria: (a) first visit between 1976 and 1998; (b) diagnosis of MO or of common migraine at the first observation, with or without association with other primary headache types; (c) <15 days per month of migraine at the first observation; and (d) at least one follow-up visit at least 10 years after the first visit. The patients thus identified were then divided into t…

AdultMalemedicine.medical_specialtyNeurologyTime FactorsAuraMigraine DisordersDermatologyYoung AdultChronic MigraineMigraine Migraine without aura Chronic migraine Chronic daily headache Chronic headacheInternal medicinemedicineHumansYoung adultDepression (differential diagnoses)business.industryDepressionGeneral MedicineMiddle Agedmedicine.diseaseComorbidityNatural historyPsychiatry and Mental healthMigraineChronic DiseaseHypertensionPhysical therapyDisease ProgressionFemaleSettore MED/26 - NeurologiaNeurology (clinical)business
researchProduct

Domain-specific trends in cognitive impairment after acute ischaemic stroke.

2012

Little is known about the pattern of subacute cognitive domain impairments after ischaemic stroke, nor the temporal evolution of such impairments. Our objective was to investigate the pattern of cognitive impairment in different neuropsychological domains up to a year after ischaemic stroke. We included prospectively collected data from an observational database of stroke patients at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. Patients were categorised into temporal groups according to the time between the index stroke and neuropsychological profiling. The prevalence of impairment in different cognitive domains was then compared between these categories. …

AdultMalemedicine.medical_specialtyNeurologyTime Factorsmedicine.medical_treatmentNeuropsychological TestsStatistics NonparametricCohort StudiesPhysical medicine and rehabilitationmedicineDementiaHumansNeuroradiologyAgedAged 80 and overischaemic strokeRehabilitationSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryNeuropsychologyCognitionMiddle Agedmedicine.diseaseStrokeNeurologyCohortPhysical therapyFemaleNeurology (clinical)Verbal memorybusinessCognition DisordersJournal of neurology
researchProduct

Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia.

2002

Sepsis in chemotherapy-associated neutropenia is a major cause of mortality in the treatment of acute myeloid leukemia (AML). Early diagnosis of sepsis is crucial for patient survival. We analyzed the value of prospectively measuring serum concentrations of soluble tumor necrosis factor receptor type II (sTNF-RII) in patients with AML for early diagnosis of sepsis in neutropenia. Therefore, 54 adult patients with AML and neutropenia were followed around the onset of fever. A total of 59 febrile episodes were documented. We could not demonstrate a significant increase in sTNF-RII levels prior to fever. sTNF-RII concentrations were not predictive of the severity of a febrile episode. Based on…

AdultMalemedicine.medical_specialtyNeutropeniaTime FactorsFevermedicine.medical_treatmentPilot ProjectsNeutropeniaInfectionsGastroenterologySeverity of Illness IndexReceptors Tumor Necrosis FactorSepsisAntigens CDhemic and lymphatic diseasesInternal medicinemedicineHumansReceptors Tumor Necrosis Factor Type IIProspective StudiesAgedChemotherapyHematologyLeukopeniabusiness.industryOsmolar ConcentrationMyeloid leukemiaHematologyGeneral MedicineMiddle Agedmedicine.diseaseSolubilityLeukemia MyeloidImmunologyAcute DiseaseTumor necrosis factor alphaFemalemedicine.symptombusinessComplicationAnnals of hematology
researchProduct

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania

2009

Background Virological response to antiretroviral treatment (ART) in rural Africa is poorly described. We examined virological efficacy and emergence of drug resistance in adults receiving first-line ART for up to 4 years in rural Tanzania. Methods Haydom Lutheran Hospital has provided ART to HIV-infected patients since October 2003. A combination of stavudine or zidovudine with lamivudine and either nevirapine or efavirenz is the standard first-line regimen. Nested in a longitudinal cohort study of patients consecutively starting ART, we carried out a cross-sectional virological efficacy survey between November 2007 and June 2008. HIV viral load was measured in all adults who had completed…

AdultMalemedicine.medical_specialtyNevirapineEfavirenzTime FactorsAnti-HIV AgentsHIV InfectionsVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Communicable diseases: 776Drug resistanceTanzanialcsh:Infectious and parasitic diseasesCohort StudiesZidovudinechemistry.chemical_compoundInternal medicineDrug Resistance ViralmedicineHumanslcsh:RC109-216Viremiabusiness.industryStavudineLamivudineResistance mutationVirologyInfectious DiseasesCross-Sectional StudieschemistryHIV-1FemalebusinessViral loadmedicine.drugResearch Article
researchProduct